According to the CDC, nearly one in three U.S. adults is living with hypertension, but just about half of them are controlling it effectively. Also known as high blood pressure, hypertension can be dangerous. It increases the force against the artery walls, and over time can lead to damage of the brain, heart, and kidneys.
Fortunately, there are many steps you can take to control your blood pressure. The first is understanding what’s considered normal versus high blood pressure.
For systolic blood pressure (the upper number), the categories are as follows:
- Normal: <120
- Elevated: 120-129
- Hypertension stage 1: 130-139
- Hypertension stage 2: 140 or higher
- Hypertensive crisis: higher than 180
For diastolic blood pressure (the lower number), the categories are:
- Normal: less than 80
- Elevated: less than 80 (and 120-129 systolic blood pressure)
- Hypertension stage 1: 80-89
- Hypertension stage 2: 90 or higher
- Hypertensive crisis: higher than 120
You can set up an appointment with your doctor’s office to have your blood pressure taken, but sometimes this service is available at pharmacies or even through home kits. Once you know where you stand, you can begin addressing your blood pressure through the following tips:
Reduce Sodium Intake
Salt raises blood pressure in many people, and it can hide in sources you wouldn’t suspect. Frozen foods, canned food, and even some beverages can be high in sodium. Ideally, you should be taking in less than 2,300 milligrams of salt each day, or 1,500 milligrams or less if you’re over the age of 50.
Incorporate Fruits & Vegetables into Your Diet
Fruits and vegetables are inherently nutritious due to their lack of sodium, cholesterol, trans fat, and saturated fat—all of which can contribute to high blood pressure. As an added bonus, they’re typically low in calories, which can help you maintain a healthy weight, and they’re also loaded with key vitamins and minerals.
Exercise can help you achieve and maintain a healthy weight, which contributes to healthy blood pressure. Adults should get at least a half-hour of moderate-intensity exercise each day, such as brisk walking. Children and teens should get an hour. While the risks of high blood pressure can be alarming, there are plenty of ways to get yours under control. Knowing your numbers and having ongoing conversations with your doctor can help you manage your blood pressure proactively.
After a decade of research, the safety and efficacy of intravenous infusion of bone-marrow-derived stem cells for therapeutic treatment in individuals with heart failure have been well established; however, until Bartolucci et al’s phase 1 / 2 randomized controlled trial of intravenous infusion umbilical cord mesenchymal stem cells (UC-MSCs) on heart disease, no clinical studies have examined the safety and efficacy of similar intravenous infusion of UC-MSCs in patients with chronic systolic heart failure (HFrEF).
Specifically, therapeutic treatment of heart failure with stem cells harvested from bone marrow has demonstrated improved cardiac function and regeneration of damaged heart tissue resulting in moderate clinical benefits in survival, left ventricular function, and improved quality of life in patients with HFrEF.
While MSCs isolated from adult bone marrow have demonstrated benefits, the invasive harvesting procedure and differentiation potential related to donor age and comorbidity associated with BM-MSC present several disadvantages when evaluating for clinical application.
On the other hand, when compared to BM-MSCs, umbilical cord-derived MSCs, or UC-MSCs, are easily attainable, demonstrate less cellular aging, and are not obstructed by potential ethical concerns.
With preclinical research demonstrating UC-MSC supporting enhanced vascular regeneration and cardiomyocyte protection, Bartolucci et al’s study aimed to evaluate the safety and efficacy of intravenous infusion of UC-derived stem cells for therapeutic treatment in individuals with heart failure.
This RIMECARD trial was the first randomized, double-blind, placebo-controlled study of intravenous infusion of allogeneic UC-MSCs in patients with chronic HFrEF. Although there has been limited experience on intravenous administration of MSCs in patients with cardiovascular diseases, it has been well established that MSC-based therapies are considered safe for therapeutic use in this application; further review of prospective clinical trials also did not detect a risk of infusion toxicity, organ system complications, infection, death, or malignancy in treated patients.
The results of the RIMECARD trial demonstrated that delivery of UC-MSCs seems safe for use in the HFrEF population with observable improvements in LVEF in patients receiving intravenous UC-MSC treatments. Researchers have proposed many potential reasons for the clinical benefits of the application of UC-MSCs among patients with heart failure including reduction in myocardial cell apoptosis, less myocardial inflammation and myocardial fibrosis, the formation of new cardiac-related blood vessels, and increased cell differentiation.
One notable observation of this study was the notable cardiomyogenic differentiation potential between UC-MSCs and BM-MSCs. It appeared that BM-MSCs presented a more favorable profile of transcription factors related to cardiac differentiation; however, findings demonstrating poor retention rates after intramyocardial injections of BM-MSCs render them potentially insufficient for what is required to be deemed clinically beneficial.
By comparison, the paracrine factors observed demonstrate a significant advantage of UC-MSCs over BM-MSCs with the most prominent difference being the expression of hepatocyte growth factor in UC-MSCs from all tested donors (BM-MSCs showed low to undetectable levels).
While further analysis and outcomes were considered limited based on small patient sample groups, IV infusion of UC-MSCs was found to be feasible and safe among patients with HFrEF, inducing no humoral immune response among test subjects. While findings suggest significant improvements in left ventricular function, functional status, and quality of life, the impact of UC-MCSs in patients with heart failure would be further supported through larger clinical trials.
Reference: (2017, September 26). Safety and Efficacy of the Intravenous Infusion of Umbilical …. Retrieved December 28, 2020, from https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.117.310712
Whether you’re living with heart disease, actively trying to prevent it, or just seeking ways to boost your overall wellness, there are many habits you can adopt to improve your cardiovascular health. Oftentimes, however, an extensive lifestyle overhaul can feel daunting. While completely revamping your diet or embarking on a new fitness journey can indeed be overwhelming, there are smaller steps you can take that can still have a big impact on heart health.
By implementing these small changes one by one, you may find that the path to a healthier lifestyle is well within reach.
Lifting small hand weights can help build muscle, which contributes to overall health. Once your weights get too light, move up to a heavier set.
Choose nuts as a healthy snack.
Nuts are filling but rich in nutrients. Next time you’re hungry between meals, reach for peanuts, almonds, or walnuts for your heart health. You can also incorporate them into salads.
Add one fruit or veggie a day.
Instead of focusing on what you should eliminate from your diet, think instead about the healthy choices you can add-in. Aim for an additional serving of vegetables or fruit each day until you’re having them with most meals. You’ll likely make fewer unhealthy choices as a natural result.
Walk for 10 minutes.
A quick walk is a simple, manageable goal you can get started on right away. As you build up endurance, increase the time by five-minute intervals until you’re walking 30 minutes per day, most days of the week.
Cut out caloric beverages.
Beverages other than water often have extra calories, sugars, and other additives which can impact your health and lead to weight gain. When possible, choose water to keep your diet in check. If you’re craving flavor, add a slice of lemon.
Have a good breakfast.
Start with a nutritional meal and you may find yourself more inclined to make healthy choices for the rest of the day. Aim to include a good source of protein, such as eggs or yogurt, so you’re full and less likely to snack before lunch.
Swap out red meat for seafood.
While you may choose to have red meat in moderation, seafood is a far better nutritional choice. Try to incorporate fish into your meals once per week to boost brain and heart health.
Try deep breathing.
High blood pressure is a major heart health concern. Deep breathing may help to keep you calm in stressful situations, which could contribute to lower blood pressure.
Wash your hands frequently.
Infections such as seasonal flu and other viruses can take their toll on heart health. Minimize your risk of infection by washing your hands frequently, and especially before eating or touching your face.
Positive emotions such as gratitude have been linked to better overall wellness and longevity. To evoke more feelings of appreciation and fulfillment, start and end each day by reflecting on what it is you have to be grateful for.
For more helpful health awareness blogs, please visit stemedix.com/blog.
A myocardial infarction, commonly known as a heart attack, occurs when blood flow through the coronary arteries is blocked. A heart attack usually happens to people with atherosclerotic coronary heart disease, which narrows one or more of the coronary arteries. A blood clot becomes lodged in the narrowed artery, preventing blood from reaching the heart muscle. Because the heart needs a virtually constant supply of oxygen-rich blood to survive, an interruption in blood flow to the heart can quickly cause muscle cells to die. There has been much talk in the medical community of using stem cells to rebuild the heart after a heart attack.
Dead heart muscle cells cannot help the heart pump blood. Thus, people who suffer a heart attack are often left with “weak” hearts. Instead of strongly squeezing blood out of the heart to the rest of the body, a larger portion of the blood remains in the heart (i.e. reduced ejection fraction). People who have had a heart attack that reduces ejection fraction commonly develop a condition known as congestive heart failure.
People with congestive heart failure often have difficult lives. Congestive heart failure patients periodically experience exacerbations that require hospitalization. They are put on restrictive diets; their salt and fluid intakes are limited. They must also take several different medications to help the heart pump blood through the arteries to the body and keep fluid levels in the body low. These medications do not heal or replace dead heart muscle cells. Instead, they make the remaining cells work harder (or decrease resistance in the arteries, or help the body eliminate fluid through urination).
What is needed is a way to regenerate dead heart muscle cells. Fortunately, several research groups are working on ways to use stem cells to regenerate heart muscle cells so that heart attack patients can regain heart muscle function.
There have been at least 11 clinical trials studying the effects of stem cells on patients with myocardial infarction. The trials show that stem cell infusion into the vein, the coronary artery, or the heart muscle itself is safe and well-tolerated by patients. Notably among the studies, patients with acute myocardial infarction who received allogeneic human mesenchymal cells intravenously had a better ejection fraction, better heart structure, and better lung function after six months than those who received a placebo. In the APOLLO trial, patients with acute myocardial infarction who received adipose-derived mesenchymal cells had half the dead heart muscle cells than those who received a placebo (i.e. lesion volume was 50% lower in treated patients).
Phase III clinical trials are considered definitive (pivotal) evidence of benefit. In phase III C-CURE trial, patients with heart failure due to coronary artery disease received autologous mesenchymal cells (i.e. their own cells, specially prepared). Treated patients enjoyed significantly increased ejection fraction (heart-pumping ability) and better functional capacity and quality of life. Other Phase II clinical trials (ADVANCE, CONCERT-CHF, TRIDENT, POSEIDON-DCM) are ongoing.
These results are welcome news for patients who suffer—or will one day suffer—from a heart attack, an event that happens in 735,000 Americans every year.
Reference: Golpanian, S. et al. (2016). Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiological Reviews. 2016 Jul; 96(3): 1127–1168
Tissue injury is common to many human diseases. Cirrhosis results in damaged, fibrotic liver tissue. Idiopathic pulmonary fibrosis and related lung diseases cause damage to lung tissue. A heart attack damages heart tissue, just as a stroke damages brain tissue. In some cases, such as minor tissue injury, the damaged tissue can repair itself. Over time, however, tissue damage becomes too great and the organ itself can fail. For example, long-standing cirrhosis can cause liver failure.
One area of active research is to find ways to protect tissue from injury or, if an injury occurs, to help the tissue repair itself before the damage becomes permanent and irreversible. Indeed, tissue repair is one of the main focuses of regenerative medicine. Likewise, one of the most promising approaches in the field of regenerative medicine is stem cell therapy. Researchers are learning that when it comes to protecting against tissue injury and promoting tissue repair, exosomes harvested from stem cells are perhaps the most attractive potential therapeutic.
Why are stem cell exosomes so promising? Exosomes are small packets of molecules that stem cells release to help the cells around them grow and flourish. While one could inject stem cells as a treatment for diseases (and they certainly do work for that purpose) it may be more effective in some cases to inject exosomes directly. So instead of relying on the stem cells to produce exosomes once they are injected into the body, stem cells can create substantial amounts of exosomes in the laboratory. Exosomes with desired properties could be concentrated and safely injected in large quantities, resulting in a potentially more potent treatment for the disease.
Indeed, researchers have shown that extracellular vesicles (exosomes and their cousins, microvesicles) can be collected from stem cells and used to treat a variety of tissue injuries in laboratory animals.
Just a few examples of this research:
- Exosomes from umbilical cord-derived mesenchymal stem cells were able to accelerate skin damage repair in rats who had suffered skin burns.
- Exosomes from the same type of stem cell protected the lungs and reduced lung blood pressure in mice with pulmonary hypertension.
- Exosomes from endothelial progenitor cells protected the kidney from damage caused by a lack of blood flow to the organ.
In this growing field of Regenerative Medicine, research is constant and building as new science evolves from stem cell studies. Researchers are closing in on the specific exosomes that may be helpful in treating human diseases caused by tissue injury.
Reference: Zhang et al. (2016). Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles. International Journal of Molecular Sciences. 2016 Feb; 17(2): 174.
People with heart failure may have trouble breathing, walking, and having a normal life. Current treatments for heart failure are aimed at making the healthy heart tissue pump harder (e.g. digoxin). On the other hand, treatments largely ignore dead heart tissue because there A myocardial infarction, better known as a heart attack, occurs when blood flow through the coronary arteries to the heart is blocked. This usually occurs when a blood clot forms in a coronary artery. Since the heart is a highly active muscle, it requires a constant supply of oxygen and nutrients to maintain its pumping function. When the heart muscle is starved of oxygen, as is the case during myocardial infarction, heart cells become dysfunctional. If blood flow through the coronary arteries (which carries oxygen to the heart) is not restored soon after a heart attack begins, those dysfunctional heart cells will die.
When heart tissue has been destroyed by a heart attack, patients are usually left with poor heart function. This can lead to congestive heart failure. One way to determine whether someone who has had a heart attack has suffered lasting heart damage is to perform an echocardiogram, or simply an “echo.” By performing an echo, doctors can estimate the heart’s ability to pump blood by measuring left ventricular function.
has been no known way to rescue it. With the discovery and use of stem cells, however, there is a chance that scientists may be able to rescue dead heart muscle and improve cardiac function.
In a study, researchers blocked the coronary arteries of experimental animals to cause myocardial infarction. Four weeks later, they injected either bone marrow-derived stem cells or adipose-tissue-derived stem cells into the heart. Impressively, blood flow significantly improved to the heart and heart function. Treated animals had substantially higher left ventricular ejection fraction, essentially reversing heart failure a full month after a heart attack. Shockingly, the researchers found that stem cells appeared to salvage dead heart tissue, meaning that the size of the damaged area was smaller after treatment.
While these incredible results will need to be replicated in humans, this research represents an exciting breakthrough in cardiology and regenerative medicine. The stem cell approach may be able to help patients who have had a heart attack, but could not get medical treatment in time to remove the clot.